Your session is about to expire
← Back to Search
Focused Ultrasound Radiosensitization for Melanoma
Study Summary
This trial will study a new therapy combining ultrasound and radiation to safely treat diseases in people.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am referred for a specific type of radiotherapy.My cancer can be targeted with a specific type of focused ultrasound.I have a confirmed diagnosis of skin cancer, including melanoma or non-melanoma types.I need help with my daily activities due to my health condition.My blood pressure is very high (over 100 mmHg diastolic).I am currently receiving immunotherapy.I am using birth control if I can have children.My kidney function is severely impaired or I am on dialysis.I cannot stay still for long periods during treatment.I haven't had heart disease or unstable blood pressure in the last 6 months.My cancer causes skin ulcers, bleeding, or discharge.I do not have severe heart, brain, kidney, or blood diseases.My skin cancer is between stage I and IV, according to AJCC guidelines.My kidney function, measured by creatinine levels, is normal or nearly normal.I cannot undergo MRI scans with contrast due to health reasons.I am 18 years old or older.I can communicate how I feel during MRg-FU treatment.I have a history of bleeding disorders.I cannot take perflutren due to health reasons.I understand the study and can give my consent.
- Group 1: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Treatment Arm been approved by the FDA?
"Treatment Arm's safety rating is 1 due to its Phase 1 status, meaning there are limited data points proving both efficacy and safety."
To what extent is the patient population participating in this clinical trial expanding?
"Affirmative. The clinicaltrials.gov website attests to the active recruitment of patients for this experiment, which was first posted on June 15th 2022 and recently modified in November 16th 2022. Currently, 20 individuals from a single medical facility are sought after for participation."
Are there vacancies for volunteers in this study?
"Clinicialtrials.gov confirms that this medical research project, which was initially posted on June 15th 2022 is actively enrolling candidates. The page has been updated as recently as November 16th of the same year."
Share this study with friends
Copy Link
Messenger